Shakhnoza Khamoydinovna Niyozova

3 ta ish

Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology, Tashkent, Uzbekistan

1. The efficacy of PARP inhibitors in the treatment of patients with synchronous breast cancer.

   Kamila Izrailbekova, Sergey Kamishov, Sunnatilla Saydullaev +4

   MaqolaPARP inhibition in cancer therapyJournal of Clinical Oncology20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.006416

2. Possibilities of long-term atezolizumab immunotherapy in patients with metastatic urothelial cancer.

   Sergey Kamishov, Mirzagaleb Tillyashaykhov, E. V. Boyko +5

   MaqolaBladder and Urothelial Cancer TreatmentsJournal of Clinical Oncology20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.006417

3. The outcomes of atezolizumab therapy in combination with carboplatin and etoposide for small-cell lung cancer.

   Sergey Kamishov, Mirzagaleb Tillyashaykhov, Abrorjon Yusupbekov +6

   MaqolaLung Cancer Research StudiesJournal of Clinical Oncology20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.006753